Genetic Counseling for Patients Considering Screening and Diagnosis for Chromosomal Abnormalities.
Clin Lab Med
; 36(2): 227-36, 2016 Jun.
Article
en En
| MEDLINE
| ID: mdl-27235908
ABSTRACT
With the introduction of cell-free DNA screening for fetal aneuploidy and chromosomal microarray for prenatal diagnostic testing, options for pregnant women have become increasingly complex. Discussions regarding options for prenatal testing for aneuploidy should occur prior to any testing and should include pertinent risks and benefits of each alternative test. There is no single screening or diagnostic test option that is the right choice for all patients; patient decisions should be based on each individual woman's values and preferences after a discussion of all options.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Diagnóstico Prenatal
/
Asesoramiento Genético
Tipo de estudio:
Diagnostic_studies
/
Etiology_studies
/
Qualitative_research
/
Risk_factors_studies
/
Screening_studies
Límite:
Female
/
Humans
/
Pregnancy
Idioma:
En
Revista:
Clin Lab Med
Año:
2016
Tipo del documento:
Article
País de afiliación:
Estados Unidos